Correction to: Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction

Hagai Tavori, Michelle Melone, Shirya Rashid

    Research output: Contribution to journalArticle

    Original languageEnglish (US)
    Pages (from-to)1491
    Number of pages1
    JournalExpert Review of Cardiovascular Therapy
    Volume12
    Issue number12
    DOIs
    StatePublished - Dec 1 2014

    Fingerprint

    LDL Cholesterol
    alirocumab

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine
    • Internal Medicine

    Cite this

    Correction to : Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction. / Tavori, Hagai; Melone, Michelle; Rashid, Shirya.

    In: Expert Review of Cardiovascular Therapy, Vol. 12, No. 12, 01.12.2014, p. 1491.

    Research output: Contribution to journalArticle

    @article{2fa421fdbd1e4a93bcd3040fcf23e9a5,
    title = "Correction to: Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction",
    author = "Hagai Tavori and Michelle Melone and Shirya Rashid",
    year = "2014",
    month = "12",
    day = "1",
    doi = "10.1586/14779072.2014.986028",
    language = "English (US)",
    volume = "12",
    pages = "1491",
    journal = "Expert Review of Cardiovascular Therapy",
    issn = "1477-9072",
    publisher = "Expert Reviews Ltd.",
    number = "12",

    }

    TY - JOUR

    T1 - Correction to

    T2 - Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction

    AU - Tavori, Hagai

    AU - Melone, Michelle

    AU - Rashid, Shirya

    PY - 2014/12/1

    Y1 - 2014/12/1

    UR - http://www.scopus.com/inward/record.url?scp=84912060549&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84912060549&partnerID=8YFLogxK

    U2 - 10.1586/14779072.2014.986028

    DO - 10.1586/14779072.2014.986028

    M3 - Article

    AN - SCOPUS:84912060549

    VL - 12

    SP - 1491

    JO - Expert Review of Cardiovascular Therapy

    JF - Expert Review of Cardiovascular Therapy

    SN - 1477-9072

    IS - 12

    ER -